Table 5.

Results of follow-up.

Items	6 months			12 months			24+ months
	LSG	LSGFD	p	LSG	LSGFD	p	LSG	LSGFD	p
Weight (Kg), mean ± SD	87.0 ± 12.9	83.0 ± 13.5	0.319	76.9 ± 11.5	71.4 ± 12.1	0.127	79.8 ± 12.2	73.7 ± 13.1	0.113
BMI (Kg/m2), mean ± SD	30.9 ± 5.1	30.8 ± 5.9	0.931	27.3 ± 4.4	23.6 ± 4.2	0.447	28.3 ± 4.2	27.3 ± 5.2	0.470
EWL (%), mean ± SD	55.2 ± 21.3	53.4 ± 27.8	0.815	76.6 ± 21.6	83.3 ± 28.5	0.371	70.2 ± 21.8	77.9 ± 31.3	0.342
TWL (%), mean ± SD	22.1 ± 7.6	20.0 ± 9.3	0.401	31.0 ± 8.2	31.2 ± 8.0	0.925	28.5 ± 8.1	29.0 ± 9.2	0.847
Other comorbidities
Sleep apnea, n (%)	7 (30.4%)	6 (27.3%)	0.815	2 (8.7%)	3 (13.6%)	0.635	2 (8.7%)	3 (13.6%)	0.560
Hypertension, n (%)	3 (13.0%)	4 (18.2%)	0.634	2 (8.7%)	2 (9.1%)	0.936	2 (8.7%)	2 (9.1%)	0.936
Diabetes, n (%)	1 (4.3%)	2 (9.1%)	0.524	0 (0%)	1(4.5%)	0.301	0 (0%)	0 (0%)	–

LSG, Laparoscopic sleeve gastrectomy; LSGFD, Laparoscopic sleeve gastrectomy with fundoplication; GERD, gastroesophageal reflux disease.